SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-078867
Filing Date
2021-06-09
Accepted
2021-06-09 17:18:16
Documents
4
Period of Report
2021-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119311d1_8k.htm 8-K 25399
2 EXHIBIT 10.1 tm2119311d1_ex10-1.htm EX-10.1 14798
3 EXHIBIT 99.1 tm2119311d1_ex99-1.htm EX-99.1 10949
4 GRAPHIC tm2119311d1_ex10-1img001.jpg GRAPHIC 2021
  Complete submission text file 0001104659-21-078867.txt   55533
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 211005984
SIC: 2834 Pharmaceutical Preparations